All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @socalurologyinstitute on TikTok · 55s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @socalurologyinstitute's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Dosing for HCG. So it's a common question. So HCG is not milligrams, it's an IU
  2. 0:07International Units. The standard is 500 IU twice a week. That said, it depends on
  3. 0:13why you're taking it and because we can increase the dose. So sometimes we have
  4. 0:18men who've been on testosterone replacement for years, their fertility has
  5. 0:22gone down and we use HCG in much higher doses. Actually a thousand IU's daily
  6. 0:28even or 200,000 IU's three times a week. So we have lots of men who take it with
  7. 0:35testosterone as 500 IU's twice a week. Some men increase the dose and take 500
  8. 0:40four times a week and it's really it's a good drug and a limitation is
  9. 0:46sometimes the cost because it is expensive but you can certainly increase
  10. 0:50the dose. The dose is based upon why you're taking it.

Dr. Bellman's HCG therapy claims need more context

Dr Gary Bellman | SoCalUrology

TikTok creator

10.2K viewsWatch on TikTok

Quick answer

HCG (human chorionic gonadotropin) is used in male hormone therapy as an LH analog to stimulate endogenous testosterone production and preserve spermatogenesis in men on exogenous testosterone. Common adjunct protocols range from 250-500 IU every other day to 500 IU twice weekly, while fertility-recovery protocols for men with TRT-induced azoospermia may use higher doses in the 1,000-3,000 IU range three times weekly under physician supervision. The 200,000 IU figure cited in this video has no basis in established clinical protocols and should not be interpreted as a dosing recommendation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Dr. Bellman's HCG therapy claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Dr. Bellman's HCG therapy claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Dr. Bellman's HCG therapy claims need more context" from Dr Gary Bellman | SoCalUrology. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: HCG (human chorionic gonadotropin) is used in male hormone therapy as an LH analog to stimulate endogenous testosterone production and preserve spermatogenesis in men on exogenous testosterone.

The reason this review is not generic is the source wording and the canonical claim label "trt replying to faizal hcg hcglevels hcgtherapy trt malefe." In this clip, the useful excerpt is: "Dosing for HCG." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

HCG works by mimicking LH to stimulate Leydig cells, which is why it can partially offset the testicular suppression caused by exogenous testosterone.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

HCG (human chorionic gonadotropin) is used in male hormone therapy as an LH analog to stimulate endogenous testosterone production and preserve spermatogenesis in men on exogenous testosterone.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • HCG (human chorionic gonadotropin) is used in male hormone therapy as an LH analog to stimulate endogenous testosterone production and preserve spermatogenesis in men on exogenous testosterone. Common adjunct protocols range from 250-500 IU every other day to 500 IU twice weekly, while fertility-recovery protocols for men with TRT-induced azoospermia may use higher doses in the 1,000-3,000 IU range three times weekly under physician supervision. The 200,000 IU figure cited in this video has no basis in established clinical protocols and should not be interpreted as a dosing recommendation.
  • 500 IU twice weekly is a commonly used HCG adjunct protocol during TRT, but Coviello et al. (2005, JCEM) showed 250 IU every other day may be sufficient for intratesticular testosterone preservation in some men.
  • HCG works by mimicking LH to stimulate Leydig cells, which is why it can partially offset the testicular suppression caused by exogenous testosterone.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • 500 IU twice weekly is a commonly used HCG adjunct protocol during TRT, but Coviello et al. (2005, JCEM) showed 250 IU every other day may be sufficient for intratesticular testosterone preservation in some men.
  • HCG works by mimicking LH to stimulate Leydig cells, which is why it can partially offset the testicular suppression caused by exogenous testosterone.
  • The 200,000 IU figure stated in this video has no support in clinical literature or guidelines and should be treated as a verbal mistake, not a dosing reference.
  • Fertility-recovery protocols after long-term TRT typically use doses in the 1,000-3,000 IU range three times weekly, often combined with other agents like clomiphene, under specialist supervision.
  • The 2020 FDA reclassification of HCG as a biologic effectively ended most compounded HCG access, making cost a genuine and documented barrier to this treatment.
  • Individual response to HCG varies significantly based on duration of prior TRT use, baseline Leydig cell function, and age, meaning no single dose protocol fits all patients.
  • Any HCG protocol for fertility or TRT support should be monitored with serial hormone labs and, for fertility goals, semen analysis to assess actual response.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @socalurologyinstitute actually say?

The creator, who appears to be from a urology practice, answered a question about HCG dosing in the context of testosterone replacement therapy. They stated that HCG is dosed in International Units, not milligrams, and described "500 IU twice a week" as "the standard" for men co-administering HCG with TRT. They also mentioned higher doses, up to "a thousand IU's daily," for men with fertility concerns after long-term testosterone use. One figure in the video stands out immediately as a likely error: "200,000 IU's three times a week." That number is almost certainly a verbal slip, and it matters whether viewers catch it.

The core message is that HCG dosing is purpose-driven, varying based on whether the goal is testicular maintenance during TRT or active fertility recovery. That framing is reasonable clinical thinking.

Does the science back this up?

Mostly, yes, but with important nuance. The 500 IU twice-weekly protocol has legitimate support in the literature as a reasonable starting point for intratesticular testosterone preservation during exogenous testosterone use. The fertility-recovery doses are also grounded in clinical practice, though evidence is thinner.

Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed that 250 IU every other day was sufficient to maintain intratesticular testosterone in men on exogenous testosterone, suggesting lower doses may work for some patients. Lipshultz et al. (2010, Journal of Sexual Medicine) documented HCG use in hypogonadal men to preserve sperm production, supporting the logic of adjunct use. For azoospermia recovery in men who've been on TRT for years, higher doses in the 1,000-3,000 IU range three times weekly appear in fertility clinic protocols, which aligns with what the creator described, minus that 200,000 IU figure.

What did they get wrong (or right)?

The creator got the conceptual framework right: HCG works by mimicking LH, stimulating the Leydig cells in the testes to produce testosterone and support spermatogenesis. The dose-purpose relationship they described is clinically sound. Calling 500 IU twice a week "the standard" is defensible, though it is more accurately a commonly used starting protocol than a universal standard.

What they got wrong, almost certainly as a verbal mistake, is "200,000 IU's three times a week." No published protocol or clinical guideline supports this dose. Standard fertility-focused HCG doses top out around 1,500 to 3,000 IU three times a week in most protocols. A dose of 200,000 IU would carry serious risks of overstimulation and is not used in male hormone therapy contexts. If a patient heard that number and ran with it, that is a real problem. The cost comment is accurate: HCG and its analog chorionic gonadotropin are expensive, and the 2020 FDA ban on compounded HCG created additional access barriers that patients legitimately face.

What should you actually know?

HCG is a legitimate clinical tool with a real evidence base. For men on TRT who want to preserve testicular function or maintain some fertility potential, co-administration is a reasonable strategy, and this video conveys that correctly. The dose range matters, and the purpose-driven framing the creator uses is how most urologists and reproductive endocrinologists actually approach it.

What this video cannot tell you is whether HCG is right for your situation, what dose is appropriate for you, or how your response will differ based on how long you have been on testosterone, your baseline LH sensitivity, or your fertility goals. Coviello et al. found meaningful individual variation in intratesticular testosterone response even at consistent doses. A single TikTok, even from a credentialed urology practice, cannot account for that. Talk to a physician who can order the right labs and monitor your response. The 200,000 IU figure should be treated as a misstatement, not a clinical recommendation.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr Gary Bellman | SoCalUrology · TikTok creator

10.2K views on this video

Replying to @faizal #hcg #hcglevels #hcgtherapy #trt #malefertility

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about 500 iu twice weekly?

500 IU twice weekly is a commonly used HCG adjunct protocol during TRT, but Coviello et al. (2005, JCEM) showed 250 IU every other day may be sufficient for intratesticular testosterone preservation in some men.

What does the video say about hcg works by mimicking lh to stimulate leydig cells,?

HCG works by mimicking LH to stimulate Leydig cells, which is why it can partially offset the testicular suppression caused by exogenous testosterone.

What does the video say about the 200,000 iu figure stated in this video has no?

The 200,000 IU figure stated in this video has no support in clinical literature or guidelines and should be treated as a verbal mistake, not a dosing reference.

What does the video say about fertility-recovery protocols after long-term trt typically use doses in the?

Fertility-recovery protocols after long-term TRT typically use doses in the 1,000-3,000 IU range three times weekly, often combined with other agents like clomiphene, under specialist supervision.

What does the video say about the 2020 fda reclassification of hcg as a biologic effectively?

The 2020 FDA reclassification of HCG as a biologic effectively ended most compounded HCG access, making cost a genuine and documented barrier to this treatment.

What does the video say about individual response to hcg varies significantly based on duration of?

Individual response to HCG varies significantly based on duration of prior TRT use, baseline Leydig cell function, and age, meaning no single dose protocol fits all patients.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr Gary Bellman | SoCalUrology, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.